03-10-2024 |
PM |
|
ANGO |
AngioDynamics, Inc. |
313.35 |
-0.11 |
-0.15 |
-0.12 |
AngioDynamics Non-GAAP EPS of -$0.11 beats by $0.04, revenue of $67.5M misses by $0.42M [10/3/2024 6:34 AM] |
6.38 |
-1.27 (-16.60%) |
7.40 |
-0.25 (-3.27%) |
5.26 - 8.25 |
2,075,880 |
380,000 |
48,117 |
|
|
16-07-2024 |
PM |
|
ANGO |
AngioDynamics, Inc. |
240.33 |
-0.06 |
-0.19 |
0.02 |
AngioDynamics beats top-line and bottom-line estimates; initiates FY25 outlook [7/16/2024 6:36 AM] |
7.49 |
1.56 (26.31%) |
6.80 |
0.87 (14.67%) |
5.26 - 9.77 |
3,283,399 |
490,000 |
59,952 |
|
|
04-04-2024 |
PM |
|
ANGO |
AngioDynamics, Inc. |
246.70 |
-0.16 |
-0.14 |
-0.03 |
AngioDynamics Non-GAAP EPS of -$0.16, revenue of $65.97M [4/4/2024 7:04 AM] |
6.42 |
0.34 (5.59%) |
6.40 |
0.32 (5.26%) |
5.26 - 11.38 |
1,268,221 |
490,000 |
34,829 |
|
|
05-01-2024 |
PM |
|
ANGO |
AngioDynamics, Inc. |
308.01 |
-0.05 |
-0.09 |
0.01 |
AngioDynamics reports mixed results; updates FY24 outlook [1/5/2024 7:09 AM] |
6.21 |
-1.54 (-19.94%) |
6.26 |
-1.49 (-19.23%) |
5.72 - 15.95 |
2,195,637 |
510,000 |
55,075 |
|
|
04-10-2023 |
PM |
|
ANGO |
AngioDynamics, Inc. |
290.00 |
-0.12 |
-0.14 |
-0.06 |
|
7.42 |
-0.18 (-2.37%) |
7.64 |
0.04 (0.53%) |
6.72 - 21.88 |
977,206 |
500,000 |
2,521 |
|
|
12-07-2023 |
PM |
7:00 AM ET (Jul 12) |
ANGO |
AngioDynamics, Inc. |
377.45 |
0.02 |
0.03 |
0.01 |
AngioDynamics Non-GAAP EPS of $0.02 in-line, revenue of $91.1M beats by $0.66M [7/12/2023 7:01 AM] |
9.79 |
-0.15 (-1.51%) |
9.48 |
-0.46 (-4.63%) |
8.18 - 24.74 |
710,349 |
280,000 |
43,595 |
|
|
30-03-2023 |
PM |
7:00 AM ET (Mar 30) |
ANGO |
AngioDynamics, Inc. |
500.92 |
-0.03 |
0.00 |
0.03 |
AngioDynamics Non-GAAP EPS of -$0.03 misses by $0.02, revenue of $80.7M misses by $2.49M [3/30/2023 7:12 AM] |
9.16 |
-3.31 (-26.54%) |
10.81 |
-1.66 (-13.31%) |
8.60 - 24.87 |
1,658,459 |
230,000 |
11,465 |
|
|
05-01-2023 |
PM |
7:00 AM ET (Jan 5) |
ANGO |
AngioDynamics, Inc. |
522.87 |
0.01 |
-0.01 |
-0.02 |
AngioDynamics Non-GAAP EPS of $0.01 beats by $0.02, revenue of $85.4M beats by $1.02M, reaffirms fiscal year 2023 outlook [1/5/2023 7:20 AM] |
15.47 |
1.87 (13.70%) |
14.70 |
1.09 (8.01%) |
11.71 - 30.00 |
1,061,111 |
340,000 |
4,209 |
|
|
06-10-2022 |
PM |
7:00 AM ET (Oct 6) |
ANGO |
AngioDynamics, Inc. |
838.86 |
-0.06 |
-0.02 |
-0.02 |
AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance [10/6/2022 7:04 AM] |
17.39 |
-4.16 (-19.33%) |
19.00 |
-2.55 (-11.83%) |
17.14 - 32.00 |
1,018,012 |
270,000 |
4,071 |
|
|
12-07-2022 |
PM |
7:00 AM ET (Jul 12) |
ANGO |
AngioDynamics, Inc. |
791.89 |
0.01 |
0.01 |
0.00 |
AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M [7/12/2022 7:12 AM] |
20.01 |
-0.03 (-0.15%) |
20.48 |
0.44 (2.20%) |
17.56 - 32.00 |
688,163 |
190,000 |
509 |
|
|
07-04-2022 |
PM |
7:00 AM ET (Apr 7) |
ANGO |
AngioDynamics, Inc. |
825.05 |
0.03 |
-0.01 |
0.02 |
AngioDynamics Non-GAAP EPS of $0.03 beats by $0.04, revenue of $73.97M misses by $2.35M [4/7/2022 7:08 AM] |
23.41 |
1.88 (8.70%) |
21.54 |
0.0 (0.00%) |
20.03 - 32.00 |
635,769 |
270,000 |
9,347 |
|
|
06-01-2022 |
PM |
7:00 AM ET (Jan 6) |
ANGO |
AngioDynamics, Inc. |
1,120 |
-0.02 |
0.00 |
0.01 |
AngioDynamics EPS misses by $0.02, beats on revenue, cuts gross margin and adj. EPS guidance [1/6/2022 7:02 AM] |
24.45 |
-3.29 (-11.86%) |
27.74 |
0.0 (0.00%) |
15.63 - 32.00 |
1,077,549 |
250,000 |
4,068 |
|
|
30-09-2021 |
PM |
7:00 AM ET (Sep 30) |
ANGO |
AngioDynamics, Inc. |
905.19 |
-0.02 |
-0.05 |
0.02 |
AngioDynamics EPS beats by $0.02, beats on revenue; boosts full year guidance [9/30/2021 7:03 AM] |
25.97 |
2.61 (11.17%) |
23.33 |
-0.03 (-0.13%) |
10.17 - 30.25 |
896,374 |
300,000 |
6,097 |
|
|
13-07-2021 |
PM |
7:00 AM ET (Jul 13) |
ANGO |
AngioDynamics, Inc. |
1,040 |
N/A |
0.00 |
-0.06 |
AngioDynamics EPS in-line, beats on revenue [7/13/2021 7:13 AM] |
27.41 |
-1.00 (-3.52%) |
27.81 |
-0.60 (-2.11%) |
8.05 - 30.25 |
562,235 |
250,000 |
528 |
|
|
30-03-2021 |
PM |
7:00 AM ET (Mar 30) |
ANGO |
AngioDynamics, Inc. |
801.80 |
0.02 |
-0.03 |
0.01 |
AngioDynamics EPS beats by $0.04, beats on revenue; increases FY21 guidance [3/30/2021 7:09 AM] |
22.25 |
1.43 (6.84%) |
21.20 |
0.37 (1.78%) |
8.05 - 23.40 |
821,004 |
360,000 |
4,493 |
|
|
07-01-2021 |
PM |
7:00 AM ET (Jan 7) |
ANGO |
AngioDynamics, Inc. |
581.82 |
0.01 |
-0.02 |
0.06 |
AngioDynamics EPS beats by $0.03, beats on revenue, reaffirms outlook [1/7/2021 7:04 AM] |
18.52 |
2.34 (14.42%) |
16.19 |
0.0 (0.00%) |
7.48 - 19.52 |
1,063,838 |
254,958 |
7,035 |
|
|
29-09-2020 |
PM |
7:00 AM ET (Sep 29) |
ANGO |
AngioDynamics, Inc. |
380.63 |
0.02 |
-0.06 |
0.08 |
AngioDynamics EPS beats by $0.09, beats on revenue [9/29/2020 7:10 AM] |
12.75 |
2.08 (19.49%) |
10.91 |
0.24 (2.22%) |
7.48 - 18.70 |
1,852,137 |
291,861 |
6,297 |
|
|
16-07-2020 |
PM |
7:00 AM ET (Jul 16) |
ANGO |
AngioDynamics, Inc. |
373.93 |
-0.06 |
-0.05 |
0.25 |
AngioDynamics EPS in-line, misses on revenue [7/16/2020 7:03 AM] |
9.56 |
-1.12 (-10.53%) |
10.68 |
0.0 (0.00%) |
7.48 - 21.90 |
395,530 |
207,987 |
7,378 |
|
|